ANG Lifesciences India Ltd
22 February 2025 13:43|BSE : 540694|NSE : None|ISIN : INE236W01016
22 February 2025 13:43|BSE : 540694
NSE : None|ISIN : INE236W01016
ANG Lifesciences India is in the business of manufacturing and sales of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsule s, dry syrups, liquid syrups and suspension, lotions etc. The Company's products portfolio comprises of major therapeutics categories such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, beta lactamase inhibitor etc.
ANG Lifesciences India is in the business of manufacturing and sales of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsule s, dry syrups, liquid syrups and suspension, lotions etc. The Company's products portfolio comprises of major therapeutics categories such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, beta lactamase inhibitor etc.
FAQs
How to buy ANG Lifesciences India Ltd shares?
What is the current Market Cap of ANG Lifesciences India Ltd?
What is the current PE and PB ratio of ANG Lifesciences India Ltd?
Open Free Demat Account
Kickstart your investment journey